Clinical Study
Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma
Table 6
2
2 Table of PET/CT with combined regional and distant metastatic disease.
| + PET/CT regional and metastatic disease | Confirmed regional and metastatic disease | | |
| Frequency percent | | | | (a) Disease present | (b) No disease | Total | ā(a) Positive test | 15 | 3 | 18 | 25.45 | 5.45 | 30.91 | ā(b) Negative test | 17 | 21 | 38 | 30.91 | 38.18 | 69.09 | Total | 32 | 24 | 56 | 56.36 | 43.64 | 100.00 |
|
|